Skip to content
Open access · CC-BY via OpenAlex

Crosstalk between Cdk5 and GSK3β: Implications for Alzheimer's Disease

Olivia Engmann

Frontiers in Molecular Neuroscience · 2009 · ▲ 98 citations

Abstract

GSK3beta and Cdk5 are the two kinases in the center of research on Alzheimer's disease (AD), involved in the pathological symptoms of AD, Abeta plaque formation, tau hyperphosphorylation and neurodegeneration. So far, both kinases have mostly been examined in isolation, leading to a schism of the research field into defenders of the GSK3beta-versus the Cdk5 hypotheses of AD. However, in this debate the fact that activities of GSK3beta and Cdk5 can influence each other deserves more attention. Recent evidence from p25 transgenic mice suggests that there is a dynamic crosstalk: during aging or prolonged overactivation of Cdk5, GSK3beta activity may alter in favor of AD pathogenesis. In this review we summarize the connections between GSK3beta and Cdk5 and discuss implications for AD hypotheses.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3389/neuro.02.002.2009
Canonical
link ↗
Fetched
2026-10-16 MST

Cite this

APA
Engmann, O. (2009). Crosstalk between Cdk5 and GSK3β: Implications for Alzheimer's Disease. <em>Frontiers in Molecular Neuroscience</em>. https://doi.org/10.3389/neuro.02.002.2009
Vancouver
Engmann O. Crosstalk between Cdk5 and GSK3β: Implications for Alzheimer's Disease. Frontiers in Molecular Neuroscience. 2009. doi:10.3389/neuro.02.002.2009.
BibTeX
@article{olivia2009Crosst, title = {Crosstalk between Cdk5 and GSK3β: Implications for Alzheimer's Disease}, author = {Olivia Engmann}, journal = {Frontiers in Molecular Neuroscience}, year = {2009}, doi = {10.3389/neuro.02.002.2009}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings